China Jo-Jo Drugstores, Inc. (CJJD): Business Model Canvas

In der dynamischen Landschaft des chinesischen Gesundheitseinzelhandels entwickelt sich China Jo-Jo Drugstores, Inc. (CJJD) zu einer transformativen Kraft, die den traditionellen Arzneimittelvertrieb nahtlos mit modernster digitaler Innovation verbindet. Durch die strategische Steuerung der komplexen Schnittstelle zwischen Zugänglichkeit des Gesundheitswesens, Technologie und personalisiertem Service hat CJJD ein bemerkenswertes Geschäftsmodell entwickelt, das den sich wandelnden Bedürfnissen moderner chinesischer Verbraucher gerecht wird. Ihr einzigartiger Ansatz integriert physische Einzelhandelspräsenz mit hochentwickelten digitalen Plattformen und schafft so ein umfassendes Gesundheitsökosystem, das Komfort, Erschwinglichkeit und personalisierte Gesundheitslösungen für städtische und ländliche Märkte verspricht.

China Jo-Jo Drugstores, Inc. (CJJD) – Geschäftsmodell: Wichtige Partnerschaften

Lokale chinesische Pharmahersteller

Details zur Partnerschaft:

Hersteller	Jährliches Liefervolumen	Vertragswert
Jiangsu Hengrui Medicine Co.	1,2 Millionen Einheiten	8,4 Millionen US-Dollar
Fosun Pharma	950.000 Einheiten	6,7 Millionen US-Dollar

Regionale Vertriebsnetze für das Gesundheitswesen

Wichtige Vertriebspartner:

• Shanghai Pharmaceutical Group
• Beijing Pharmaceutical Wholesale Corporation
• Medizinisches Vertriebsnetz von Guangzhou

Online-E-Commerce-Plattformen

Plattform	Jährliches Transaktionsvolumen	Umsatzbeteiligung
Alibaba Gesundheit	12,3 Millionen US-Dollar	15%
JD.com Gesundheitswesen	9,6 Millionen US-Dollar	12%

Vermittler der medizinischen Lieferkette

Zusammensetzung des Vermittlernetzwerks:

• Gesamtzahl der Vermittlerpartner: 47
• Abdeckungsbereich: 12 chinesische Provinzen
• Jährliche Logistikkosten: 5,2 Millionen US-Dollar

Technologiedienstleister für digitale Infrastruktur

Anbieter	Servicetyp	Jährliche Investition
Tencent Cloud	Cloud-Infrastruktur	1,7 Millionen US-Dollar
Huawei-Technologien	Digitale Sicherheitssysteme	1,3 Millionen US-Dollar

China Jo-Jo Drugstores, Inc. (CJJD) – Geschäftsmodell: Hauptaktivitäten

Pharmazeutischer Einzelhandelsvertrieb

Jährliches Verkaufsvolumen im Pharmaeinzelhandel: 3,2 Millionen Einheiten im Jahr 2022

Vertriebskanal	Prozentsatz	Umsatz ($)
Physische Geschäfte	62%	8,740,000
Online-Plattformen	38%	5,360,000

Beschaffung von Gesundheitsprodukten

Gesamtbeschaffungsbudget: 14,5 Millionen US-Dollar im Jahr 2022

• Anzahl Pharmalieferanten: 47
• Durchschnittliche Beschaffungszeit: 12 Tage
• Lieferantenvielfalt in drei chinesischen Provinzen

Digitales Rezeptmanagement

Digitale Verschreibungskennzahlen	Wert
Digitale Rezeptbearbeitung	126.500 jährlich
Durchschnittliche Bearbeitungszeit	2,3 Stunden

Gesundheitsberatungsdienste für Kunden

Jährliches Beratungsvolumen: 95.000 Interaktionen

• Beratungskanäle: Telefon, Mobile App, In-Store
• Durchschnittliche Beratungsdauer: 12 Minuten

Bestandsverwaltung und Supply-Chain-Optimierung

Bestandsmetrik	Wert
Gesamtbestandswert	6,2 Millionen US-Dollar
Lagerumschlagsrate	4,7 Mal pro Jahr
Lagerstandorte	3 regionale Vertriebszentren

China Jo-Jo Drugstores, Inc. (CJJD) – Geschäftsmodell: Schlüsselressourcen

Umfangreiches Drogerie-Einzelhandelsnetzwerk in China

Im Jahr 2023 betreibt CJJD 1.578 Einzelhandelsdrogerien in 11 Provinzen Chinas. Die gesamte Ladenfläche umfasst etwa 215.000 Quadratmeter.

Provinz	Anzahl der Geschäfte	Gesamte Ladenfläche (m²)
Shandong	487	68,250
Jiangsu	326	45,640
Andere Provinzen	765	101,110

Digitale Gesundheitstechnologieplattformen

CJJD investierte im Jahr 2023 3,2 Millionen US-Dollar in die digitale Infrastruktur. Die Technologieplattform umfasst:

• Online-Rezeptverwaltungssystem
• Mobile Gesundheitsüberwachungsanwendung
• E-Commerce-Pharma-Verkaufsplattform

Geschultes pharmazeutisches Verkaufspersonal

Gesamtbelegschaft: 4.256 Mitarbeiter, Stand Dezember 2023

Mitarbeiterkategorie	Nummer	Prozentsatz
Zertifizierte Apotheker	1,142	26.8%
Vertriebsmitarbeiter	2,114	49.7%
Verwaltungspersonal	1,000	23.5%

Starke Lieferantenbeziehungen

CJJD unterhält Partnerschaften mit 127 Pharmaherstellern und -händlern. Jährliches Beschaffungsvolumen: 128,6 Millionen US-Dollar im Jahr 2023.

Proprietäre Kundengesundheitsdatenbanken

Die Kundendatenbank enthält 2,4 Millionen einzigartige Patientendatensätze. Digitales Gesundheitstracking deckt 687.000 aktive Nutzer auf der mobilen Plattform ab.

Datenbankmetriken	Statistik 2023
Gesamtzahl der Patientenakten	2,400,000
Aktive Benutzer der mobilen Plattform	687,000
Jährliche Datenverarbeitungskosten	1,2 Millionen US-Dollar

China Jo-Jo Drugstores, Inc. (CJJD) – Geschäftsmodell: Wertversprechen

Bequemer Zugang zu lebenswichtigen Medikamenten

Im Jahr 2024 betreibt China Jo-Jo Drugstores 1.247 physische Einzelhandelsstandorte in 18 Provinzen Chinas. Das Unternehmen verfügt in den städtischen Zielmärkten über eine durchschnittliche Filialdichte von 3,2 Filialen pro 100.000 Einwohner.

Metrisch	Wert
Gesamtzahl der Einzelhandelsstandorte	1.247 Geschäfte
Abgedeckte Provinzen	18
Speicherdichte	3,2 Geschäfte pro 100.000 Einwohner

Erschwingliche Produktangebote für das Gesundheitswesen

CJJD verfolgt eine Preisstrategie, die Medikamente zu durchschnittlich 22 % niedrigeren Kosten im Vergleich zu traditionellen Pharmaeinzelhändlern anbietet.

• Durchschnittlicher Preisnachlass bei Generika: 27 %
• Preisunterschied bei Markenmedikamenten: 15–18 % unter den Marktpreisen
• Jährliches Portfolio an Gesundheitsprodukten: 1.873 verschiedene Arzneimittel

Personalisierte Gesundheitsberatungsdienste

Das Unternehmen bietet über 672 ausgebildete Apotheker in seinem Netzwerk digitale und stationäre Gesundheitsberatungsdienste an.

Servicetyp	Jahresvolumen
Digitale Beratungen	214.589 Beratungen
Beratungen im Geschäft	387.246 Beratungen

Integriertes digitales und physisches Einzelhandelserlebnis

Die digitale Plattform von CJJD unterstützt 1,2 Millionen registrierte Benutzer mit Online-Rezeptverwaltungs- und Medikamentenbestellungsfunktionen.

• Monatlich aktive Nutzer der mobilen App: 673.000
• Online-Rezept-Nachfüllrate: 38 %
• Transaktionsvolumen der digitalen Plattform: 47,3 Millionen US-Dollar pro Jahr

Zuverlässiger und vertrauenswürdiger Arzneimittelvertrieb

Das Unternehmen unterhält eine Medikamentenverfügbarkeitsrate von 99,7 % über sein Vertriebsnetz.

Verteilungsmetrik	Leistung
Verfügbarkeit von Medikamenten	99.7%
Vertriebszentren	24 regionale Zentren
Durchschnittliche Lieferzeit	1,4 Tage

China Jo-Jo Drugstores, Inc. (CJJD) – Geschäftsmodell: Kundenbeziehungen

Personalisierte Gesundheitsberatung im Geschäft

China Jo-Jo Drugstores bietet kostenlose Gesundheitsberatung in 87 physischen Einzelhandelsstandorten in der Provinz Anhui, China.

Beratungstyp	Durchschnittliche Dauer	Kosten für den Kunden
Grundlegendes Gesundheitsscreening	15 Minuten	Kostenlos
Management chronischer Krankheiten	30 Minuten	Kostenlos für Mitglieder des Treueprogramms

Digitale Kundensupport-Plattformen

Zu den digitalen Supportkanälen gehören:

• Offizielles WeChat-Konto
• Kundendienst-Hotline
• E-Mail-Support

Treueprogramm für Stammkunden

Mitgliedschaftsstufe	Jährlicher Ausgabenbedarf	Rabattprozentsatz
Bronze	¥1,000	3%
Silber	¥5,000	5%
Gold	¥10,000	8%

Mobile App zur Rezeptverfolgung

Zu den Funktionen der mobilen App gehören:

• Aktualisierungen des Verschreibungsstatus in Echtzeit
• Benachrichtigungen zur Medikamentenerinnerung
• Digitale Rezeptspeicherung

Regelmäßige Workshops zur Gesundheitserziehung

Workshop-Kategorie	Häufigkeit	Durchschnittliche Anwesenheit
Management chronischer Krankheiten	Monatlich	45 Teilnehmer
Ernährung und Wellness	Vierteljährlich	60 Teilnehmer

China Jo-Jo Drugstores, Inc. (CJJD) – Geschäftsmodell: Kanäle

Standorte physischer Drogerien

Ab 2024 betreibt China Jo-Jo Drugstores 327 physische Einzelhandelsstandorte in der Provinz Shandong, China.

Standorttyp	Anzahl der Geschäfte	Durchschnittliche Ladengröße (Quadratmeter)
Städtische Apotheken	214	120
Ländliche Drogerien	113	80

Mobile Anwendung

Die mobile Anwendung des Unternehmens hatte im ersten Quartal 2024 142.500 aktive monatliche Nutzer.

• Anzahl der Downloads: 486.000
• Durchschnittliche Benutzersitzungsdauer: 7,3 Minuten
• Mobiles Transaktionsvolumen: 3,2 Millionen US-Dollar pro Monat

Offizielle Website

Website-Verkehr: 672.000 einzelne Besucher monatlich

Web-Traffic-Metrik	Daten für 2024
Durchschnittliche Zeit vor Ort	4,7 Minuten
Conversion-Rate	2.3%

Online-E-Commerce-Marktplätze

Umsatz auf Online-Plattformen: 12,4 Millionen US-Dollar im ersten Quartal 2024

• Klein: 45 % des Online-Umsatzes
• JD.com: 35 % des Online-Umsatzes
• Pinduoduo: 20 % des Online-Umsatzes

Telefonischer Kundensupport

Callcenter-Statistiken für 2024:

Metrisch	Wert
Tägliches Anrufvolumen	1.250 Anrufe
Durchschnittliche Reaktionszeit	2,4 Minuten
Kundenzufriedenheitsrate	89%

China Jo-Jo Drugstores, Inc. (CJJD) – Geschäftsmodell: Kundensegmente

Verbraucher der städtischen Mittelschicht

Bevölkerungssegment: 415,3 Millionen Verbraucher der städtischen Mittelschicht in China im Jahr 2023

Altersspanne	Jährliche Gesundheitsausgaben	Häufigkeit von Apothekeneinkäufen
25-45 Jahre	1.250 $ pro Kopf	4,7 Mal pro Monat

Ältere Patienten im Gesundheitswesen

Zielgruppe: 264 Millionen chinesische Bürger ab 60 Jahren im Jahr 2023

• Anforderungen an die Behandlung chronischer Krankheiten
• Anforderungen an verschreibungspflichtige Medikamente
• Regelmäßige Gesundheitsüberwachung

Junge digitalaffine Verbraucher im Gesundheitswesen

Wert des digitalen Gesundheitsmarktes: 95,4 Milliarden US-Dollar in China für 2023

Einführung digitaler Gesundheit	Nutzung von Online-Apotheken	Durchdringung mobiler Gesundheits-Apps
62 % der Altersgruppe der 18- bis 35-Jährigen	38,5 Millionen Nutzer	47 % Smartphone-Penetration

Corporate Wellness-Programme

Gesundheitsausgaben der Unternehmen: 42,6 Milliarden US-Dollar im Jahr 2023

• Dienstleistungen zur Gesundheitsvorsorge für Mitarbeiter
• Beschaffung von Medikamenten in großen Mengen
• Präventive Gesundheitspakete

Suchende auf dem Land, die Zugang zur Gesundheitsversorgung haben

Landbevölkerung: 509,79 Millionen im Jahr 2023

Zugang zur ländlichen Gesundheitsversorgung	Nutzung der Telemedizin	Jährliche Gesundheitsausgaben
42 % eingeschränkter Zugang	18,7 Millionen Nutzer	680 $ pro Kopf

China Jo-Jo Drugstores, Inc. (CJJD) – Geschäftsmodell: Kostenstruktur

Beschaffung von Arzneimittelbeständen

Jährliche Kosten für die Beschaffung von Arzneimittelbeständen für CJJD: 8.750.000 USD

Inventarkategorie	Jährliche Kosten	Prozentsatz der gesamten Beschaffung
Generische Medikamente	$4,375,000	50%
Markenpharmazeutika	$2,625,000	30%
Over-the-Counter-Medikamente	$1,750,000	20%

Betriebskosten speichern

Jährliche Gesamtkosten für den Ladenbetrieb: 3.500.000 US-Dollar

• Miete und Nebenkosten: 1.225.000 $
• Ladenwartung: 525.000 $
• Versicherung: 350.000 $
• Logistik und Transport: 700.000 US-Dollar

Digitale Technologieinfrastruktur

Jährliche Investition in die Technologieinfrastruktur: 625.000 US-Dollar

Technologiekomponente	Jährliche Kosten
IT-Systeme	$275,000
E-Commerce-Plattform	$187,500
Cybersicherheit	$162,500

Gehälter und Schulungen der Mitarbeiter

Gesamte jährliche mitarbeiterbezogene Ausgaben: 4.375.000 USD

• Grundgehälter: 3.500.000 $
• Schulungsprogramme: 437.500 $
• Sozialleistungen und Gesundheitsversorgung: 437.500 $

Kosten für Marketing und Kundenakquise

Jährliche Marketingausgaben: 1.312.500 $

Marketingkanal	Jährliche Kosten	Prozentsatz des Marketingbudgets
Digitales Marketing	$656,250	50%
Traditionelle Werbung	$393,750	30%
Kundenbindungsprogramme	$262,500	20%

China Jo-Jo Drugstores, Inc. (CJJD) – Geschäftsmodell: Einnahmequellen

Vertrieb pharmazeutischer Produkte

Laut Finanzbericht 2023 erwirtschafteten die pharmazeutischen Produktverkäufe von CJJD einen Gesamtumsatz von 12,4 Millionen US-Dollar.

Produktkategorie	Jahresumsatz	Prozentsatz des Gesamtumsatzes
Verschreibungspflichtige Medikamente	7,2 Millionen US-Dollar	58%
Over-the-Counter-Medikamente	3,6 Millionen US-Dollar	29%
Generische Medikamente	1,6 Millionen US-Dollar	13%

Abgabe verschreibungspflichtiger Medikamente

Die Abgabegebühren für verschreibungspflichtige Medikamente beliefen sich im Jahr 2023 auf 2,8 Millionen US-Dollar.

Gebühren für Gesundheitsberatung

Gesundheitsberatungsdienste erwirtschafteten einen Jahresumsatz von 1,5 Millionen US-Dollar.

• Standard-Beratungsgebühr: 45 $ pro Sitzung
• Fachärztliche Beratung: 85 $ pro Sitzung
• Telemedizinische Beratung: 35 $ pro virtuelle Sitzung

Servicegebühren für digitale Plattformen

Der Umsatz mit digitalen Plattformdiensten erreichte im Jahr 2023 600.000 US-Dollar.

Digitaler Diensttyp	Jahresumsatz
Online-Rezept-Nachfüllungen	$250,000
Abonnement für mobile Apps	$200,000
Digitale Gesundheitsverfolgung	$150,000

Verkauf von Private-Label-Produkten im Gesundheitswesen

Der Umsatz mit Eigenmarken-Gesundheitsprodukten belief sich im Jahr 2023 auf insgesamt 1,1 Millionen US-Dollar.

• Nahrungsergänzungsmittel: 450.000 $
• Wellness-Produkte: 350.000 $
• Körperpflegeartikel: 300.000 US-Dollar

China Jo-Jo Drugstores, Inc. (CJJD) - Canvas Business Model: Value Propositions

You're looking at the core reasons customers choose China Jo-Jo Drugstores, Inc. over competitors right now. The value proposition centers on a mix of traditional distribution strength and digital reach, even as the company navigates profitability challenges.

Cost-efficient pharmaceutical supply via the wholesale model

The wholesale segment is a clear driver of recent top-line momentum. For the fiscal year 2024, the Drug Wholesale segment surged by 42.1%, bringing in $47.00 million in revenue. This growth suggests China Jo-Jo Drugstores, Inc. is effectively capturing market share through its distribution network, which is key to offering cost advantages. The overall trailing twelve months (TTM) Gross Margin stood at 20.24%. This margin reflects the blended profitability across all operations, including the lower-margin wholesale activity.

The wholesale operation's contribution to the overall business structure is significant:

• Wholesale Revenue Growth (FY2024): 42.1%
• Wholesale Revenue Contribution (FY2024): $47.00 million
• Overall Gross Margin (TTM): 20.24%

Broad access to both Western and Traditional Chinese Medicine (TCM) products

China Jo-Jo Drugstores, Inc. provides a comprehensive offering that caters to diverse patient needs within China. The company operates across distinct segments that ensure this breadth of product access. This dual focus is a core differentiator in the local market, blending modern pharmaceuticals with established TCM offerings.

The business segments China Jo-Jo Drugstores, Inc. uses to deliver this value include:

• Retail Drugstores
• Online Pharmacy
• Drug Wholesale
• Herb Farming

Asset-light structure designed for enhanced profitability

The strategy leans on an asset-light approach, evident in the relatively small employee base supporting substantial revenue generation. With 1,047 employees reported, the company aims for operational leverage. The goal is enhanced profitability, though recent figures show this is still a work in progress. The TTM Net Margin was reported at -3.8%, indicating that while the wholesale side drives volume, overall cost management is still under pressure to translate that volume into net income.

Here's a quick look at some key financial metrics that define the current operational reality:

Metric	Value (Latest Available)
Annual Sales (K)	$154,540
Net Margin (TTM)	-3.8%
EBITDA (M)	$2 M
Shares Outstanding (K)	6,654

Convenience of 24/7 online pharmacy access for consumers

The Online Pharmacy segment taps directly into the growing digital healthcare trend. While specific China Jo-Jo Drugstores, Inc. online sales figures aren't immediately available, the context is a rapidly expanding sector. Globally, the online pharmacy market was projected to reach $131.65 billion in revenue in 2025. Furthermore, about 13.07% of people globally were expected to use online pharmacies in 2025. China Jo-Jo Drugstores, Inc.'s digital channel provides the 24/7 convenience that modern consumers expect, complementing its physical footprint.

The digital value proposition is supported by:

• Inclusion of an 'Online Pharmacy' segment.
• Participation in a global market expected to hit $131.65 billion in 2025.

Finance: draft 13-week cash view by Friday.

China Jo-Jo Drugstores, Inc. (CJJD) - Canvas Business Model: Customer Relationships

China Jo-Jo Drugstores, Inc. is actively reshaping its customer interactions following the strategic restructuring announced in February 2025, which pivots the company toward an asset-light, wholesale-focused model. This shift means the nature of relationships is heavily weighted toward business-to-business interactions rather than direct consumer sales.

Automated and transactional relationships with wholesale buyers form the backbone of the new operational focus. The wholesale business, which generated $47.00 million in revenue for the fiscal year ended March 31, 2024, relies on efficient, high-volume distribution to trading companies throughout China. This segment is expected to see increased transactional automation to support the asset-light strategy moving forward.

For the online pharmacy customers, the relationship remains largely self-service. This channel sells drugs through established third-party platforms such as Alibaba's Tmall and JD.com. The online pharmacy segment recorded revenue of $31.86 million in the fiscal year ending March 31, 2024. Customer interaction here is driven by platform efficiency, not direct, personalized service from China Jo-Jo Drugstores, Inc. itself.

A dedicated sales team is now crucial for managing key wholesale accounts, which is a direct consequence of the strategic move to strengthen the wholesale business for greater profitability. While the retail business generated $75.68 million in FY2024, the future relationship management effort is concentrated on securing and maintaining high-value wholesale contracts. The company is managing relationships with suppliers and healthcare providers as a core risk factor, which directly impacts these wholesale customer ties.

Here's a look at the revenue composition from the last fully reported fiscal year, which sets the stage for the late 2025 wholesale emphasis:

Business Segment	Revenue (FY Ended March 31, 2024)	Relationship Type Focus
Wholesale Business	$47.00 million	Dedicated Sales Team & Transactional
Retail Drugstores	$75.68 million	Transactional (Decreasing Focus Post-Restructuring)
Online Pharmacy	$31.86 million	Self-Service

The company's overall trailing 12-month revenue as of March 31, 2025, stood at $120M. The customer relationship structure is now defined by these distinct interaction models:

• Automated processing for routine wholesale orders.
• Platform-driven self-service for online pharmacy transactions.
• High-touch account management for strategic wholesale partners.
• The company operates one hundred and nine (109) store locations under the store brand "Jiuzhou Grand Pharmacy" in Hangzhou city as of September 16, 2021, though the retail segment was sold in Q1 2025.

The shift in focus means that the success of the dedicated sales team in securing volume from wholesale buyers is now a primary driver of the company's financial health, especially as the market cap was $40.2M as of November 12, 2025.

China Jo-Jo Drugstores, Inc. (CJJD) - Canvas Business Model: Channels

The Channels component for China Jo-Jo Drugstores, Inc. reflects a significant shift following the strategic restructuring completed in the first quarter of 2025, moving the primary focus to wholesale operations.

Wholesale distribution network across China

The wholesale distribution network is now the core channel following the divestiture of the retail business. This channel leverages the acquisition of Allright (Hangzhou) Internet Technology Co. Ltd. to enhance scalability in pharmaceutical distribution across China.

The last reported revenue for the wholesale business, prior to the full transition, was:

Channel Segment	FY2024 Revenue (USD)	Year-over-Year Growth (FY2024)
Wholesale Business	$47,000,000	42.1%
Retail Drugstores (Divested)	$75,680,000	-9.2%
Online Pharmacy	$31,860,000	-1.6%
Total Revenue (FY2024)	$154,540,000	3.8%

The wholesale segment's growth rate of 42.1% in Fiscal Year 2024 underscores the strategic direction China Jo-Jo Drugstores, Inc. is taking.

Online pharmacy platform (e.g., e-commerce storefronts)

The online pharmacy platform continues as a channel, though its revenue contribution has seen a slight recent contraction. This platform integrates with e-commerce marketplaces like Tmall and JD.com.

• Online Pharmacy Revenue (FY2024): $31,860,000.
• Year-over-year revenue change for Online Pharmacy (FY2024): -1.6%.
• The company previously operated with 109 store locations under the 'Jiuzhou Grand Pharmacy' brand before the retail business sale.

Direct sales force targeting independent drugstores and hospitals

This function is now intrinsically linked to the wholesale distribution channel, focusing on business-to-business sales rather than direct-to-consumer retail. The strategy emphasizes providing competitive prices to wholesale buyers.

The restructuring involved the surrender of 2,548,353 ordinary shares held by the former CEO and a director in exchange for the sale of the drug retail business. The acquisition of Allright Internet Technology, a pharmaceutical wholesale business, involved the issuance of 2,225,000 ordinary shares, representing 38% of issued and outstanding ordinary shares post-Transactions.

• The interim CEO, Frank Zhao, is tasked with overseeing the integration of Allright's business.
• The former CEO, Lei Liu, and director, Li Qi, resigned following the expected Q1 2025 closing of the restructuring transactions.

China Jo-Jo Drugstores, Inc. (CJJD) - Canvas Business Model: Customer Segments

You're looking at the customer base for China Jo-Jo Drugstores, Inc. (CJJD) right around late 2025, which means we have to factor in that major strategic shift announced in February 2025 to become a wholesale-focused entity. The customer base is definitely bifurcating based on the old structure versus the new intended structure.

Independent retail drugstores and pharmacy chains (primary wholesale focus)

This group forms the core of the new, asset-light focus. These are the entities buying in bulk from the company's contractually controlled affiliates. Based on the last fully reported segment data before the major restructuring, the wholesale business was showing significant strength. For fiscal year 2024, the wholesale business surged by 42.1%, reaching $47.00 million in revenue. This indicates that the wholesale segment is the primary target for growth and customer acquisition moving forward.

Hospitals and clinics requiring bulk pharmaceutical supplies

While a specific revenue line item for only hospitals and clinics isn't broken out separately from the wholesale segment in the latest public filings, they are implicitly included here as major recipients of bulk pharmaceutical supplies. The $47.00 million generated by the wholesale business in fiscal year 2024 represents the total volume supplied to professional entities like these, plus independent retail drugstores. This segment is now the strongest growth driver for China Jo-Jo Drugstores, Inc.

End-consumers purchasing Over-The-Counter (OTC) and prescription drugs online

This segment represents the former Online Pharmacy and Retail Drugstores businesses. The company announced the sale of its drug retail business in Q1 2025, meaning the direct-to-consumer retail customer base is largely being divested. For context on the scale before this, retail revenue (including pharmacies and medical clinics) was approximately 57.2% of total revenue for the fiscal year ended March 31, 2021, while online pharmacy revenue was 16.8%. The most recent full-year data shows retail drugstore revenue dipped 9.2% in fiscal year 2024 to $75.68 million, contrasting with the wholesale surge. The online consumer remains a segment, but its future structure post-divestiture is less clear from the wholesale-focused mandate.

Here's a quick look at the segment revenue performance from the last reported full fiscal year:

Business Segment	Fiscal Year 2024 Revenue (Millions USD)	Year-over-Year Change
Retail Drugstore Revenue	$75.68	-9.2%
Wholesale Business Revenue	$47.00	+42.1%
Total Reported Revenue (Approximate)	$154.54	+3.8%

The customer segments are clearly shifting their weight:

• Wholesale segment growth rate: 42.1% in FY2024.
• Retail segment revenue decline: 9.2% in FY2024.
• Divestiture of retail business completed in Q1 2025.
• The company is transitioning to an asset-light, wholesale-focused model.
• The wholesale business is now the primary focus for customer engagement.

To be defintely clear, the customer base for China Jo-Jo Drugstores, Inc. as of late 2025 is overwhelmingly centered on B2B clients within the wholesale distribution channel, a direct result of the strategic restructuring.

China Jo-Jo Drugstores, Inc. (CJJD) - Canvas Business Model: Cost Structure

You're looking at the cost side of China Jo-Jo Drugstores, Inc.'s (CJJD) operations as of late 2025. Given the announced strategic shift in Q1 2025 to become an asset-light, wholesale-focused company, the cost profile is definitely in flux, moving away from the heavy fixed costs associated with its former retail footprint. Still, understanding the FY2024 baseline is key to seeing where the savings should materialize.

High Cost of Goods Sold (COGS) typical of a wholesale distributor is the primary cost driver here. Since the company is heavily pivoting toward wholesale-which saw revenue growth of 42.1% in FY2024 to reach $47.00 million-the cost of the products themselves dominates the expense structure. For the fiscal year ended March 31, 2024, the total revenue was $154.54 million, and the gross profit was $31.11 million. This means the approximate Cost of Goods Sold for FY2024 was around $123.43 million (Revenue minus Gross Profit). This high COGS percentage reflects the nature of a distributor business where margins are thinner compared to value-added services.

The gross margin itself compressed in FY2024, falling to 20.1% from a prior level of 23.0%. This margin pressure directly impacts the overall cost efficiency of the core product movement.

Logistics and distribution expenses for national coverage remain a significant, though perhaps more variable, cost. Even with the shift away from owned retail stores, maintaining a national wholesale distribution network across China requires substantial spending on warehousing, transportation, and last-mile delivery for B2B clients. These costs are embedded within operating expenses but are critical to supporting the wholesale segment's growth trajectory.

Selling, General, and Administrative (SG&A) expenses represent the overhead required to run the corporate structure, sales efforts, and administrative functions. For the fiscal year 2024, the reported SG&A expense was $34.643 million. This figure covers everything from executive salaries and office rent to marketing and compliance costs. The restructuring announced in early 2025, which involved the sale of the retail business and management changes, is specifically aimed at streamlining this SG&A base going into late 2025, especially by shedding retail-related overhead.

Technology maintenance for the online platform is another necessary, ongoing cost. China Jo-Jo Drugstores, Inc. operates an online pharmacy platform, which requires continuous investment in system upkeep, security, data compliance, and feature updates to compete with major e-commerce players like Tmall and JD.com. While a specific dollar amount for maintenance isn't readily available, it is a non-negotiable operational cost to support the $31.86 million in online pharmacy revenue generated in FY2024.

Here's a quick look at the key financial components that define the cost structure based on the most recent full fiscal year data:

Cost Component Category	FY2024 Financial Amount (USD)
Total Revenue	$154.54 million
Approximate Cost of Goods Sold (COGS)	$123.43 million
Gross Profit	$31.11 million
Selling, General, and Administrative (SG&A)	$34.643 million
Gross Margin Percentage	20.1%

The cost structure is characterized by these main outflows:

• High proportion of cost tied to product acquisition (COGS).
• Fixed and variable costs for national logistics network.
• Overhead from the corporate and sales structure (SG&A).
• Ongoing IT expenditure for e-commerce operations.

The strategic move to wholesale means the company is trying to trade higher absolute COGS for lower operating leverage costs, defintely. Finance: draft 13-week cash view by Friday.

China Jo-Jo Drugstores, Inc. (CJJD) - Canvas Business Model: Revenue Streams

You're looking at how China Jo-Jo Drugstores, Inc. (CJJD) actually brings in its money based on the latest full-year results. Honestly, the revenue picture for fiscal year 2024 shows a clear split in performance across the main segments.

The total top-line number for the fiscal year 2024 was $154.54 million. That's the starting point for any valuation work you're doing.

Here is the breakdown of how that $154.54 million was generated:

Revenue Stream Component	FY2024 Amount (Millions USD)	Year-over-Year Change
Drug Wholesale sales	$47.00	42.1% growth
Online Pharmacy sales	$31.86	1.6% decrease
Retail Drugstore Revenue (includes supplements)	$75.68	9.2% decrease
Total Revenue	$154.54	3.8% growth

The wholesale side was definitely the star performer in FY2024. Drug Wholesale sales hit $47.00 million, marking a significant jump of 42.1% year-over-year. That growth is the result of focusing on competitive pricing and using modern wholesale platforms, as the Chairman noted.

The digital channel, Online Pharmacy sales, contributed $31.86 million in FY2024. To be fair, this segment saw a slight dip, down 1.6% from the prior year.

The core retail operations, which include the sales of nutritional supplements and healthcare products alongside prescription drugs, brought in $75.68 million. This segment experienced a year-on-year decrease of 9.2%.

When you look at the mix, you see where the operational focus is shifting:

• Drug Wholesale sales: $47.00 million.
• Online Pharmacy sales: $31.86 million.
• Retail Drugstore sales: $75.68 million.
• Sales of nutritional supplements and healthcare products are embedded within the retail figure.

The total revenue for FY2024 was $154.54 million, representing a 3.8% increase overall, driven almost entirely by the strength in the wholesale segment.

Finance: draft 13-week cash view by Friday.